90 related articles for article (PubMed ID: 38429685)
1. A cost-benefit analysis of mass prostate cancer screening.
Farabi H; Moradi N; Ahmadzadeh A; Aghamir SMK; Mohammadi A; Rezapour A
Cost Eff Resour Alloc; 2024 May; 22(1):37. PubMed ID: 38705990
[TBL] [Abstract][Full Text] [Related]
2. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
[TBL] [Abstract][Full Text] [Related]
3. A cost-benefit analysis of genetic screening test for breast cancer in Iran.
Meshkani Z; Moradi N; Aboutorabi A; Farabi H; Moini N
BMC Cancer; 2024 Mar; 24(1):279. PubMed ID: 38429685
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Manchanda R; Patel S; Gordeev VS; Antoniou AC; Smith S; Lee A; Hopper JL; MacInnis RJ; Turnbull C; Ramus SJ; Gayther SA; Pharoah PDP; Menon U; Jacobs I; Legood R
J Natl Cancer Inst; 2018 Jul; 110(7):714-725. PubMed ID: 29361001
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
[TBL] [Abstract][Full Text] [Related]
6. Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
D'Andrea E; Marzuillo C; De Vito C; Di Marco M; Pitini E; Vacchio MR; Villari P
Genet Med; 2016 Dec; 18(12):1171-1180. PubMed ID: 27906166
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Tuffaha HW; Mitchell A; Ward RL; Connelly L; Butler JRG; Norris S; Scuffham PA
Genet Med; 2018 Sep; 20(9):985-994. PubMed ID: 29300376
[TBL] [Abstract][Full Text] [Related]
8. The direct medical cost of breast cancer management in a provincial hospital of Papua New Guinea: A cost of illness study of consecutive patients from 2017 to 2022.
Umo I; Kulai M; Umo P; James K; Ikasa R
J Cancer Policy; 2023 Dec; 38():100447. PubMed ID: 37813161
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of breast cancer: a case of Southern Iran.
Jalali FS; Keshavarz K; Seif M; Akrami M; Jafari A; Ravangard R
Cost Eff Resour Alloc; 2023 Aug; 21(1):58. PubMed ID: 37644546
[TBL] [Abstract][Full Text] [Related]
10. Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer.
Meshkani Z; Moradi N; Aboutorabi A; Jafari A; Shams R
BMC Public Health; 2023 Apr; 23(1):667. PubMed ID: 37041634
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review.
Velentzis LS; Freeman V; Campbell D; Hughes S; Luo Q; Steinberg J; Egger S; Mann GB; Nickson C
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831466
[TBL] [Abstract][Full Text] [Related]
12. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050.
Chen S; Cao Z; Prettner K; Kuhn M; Yang J; Jiao L; Wang Z; Li W; Geldsetzer P; Bärnighausen T; Bloom DE; Wang C
JAMA Oncol; 2023 Apr; 9(4):465-472. PubMed ID: 36821107
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Schousboe JT; Sprague BL; Abraham L; O'Meara ES; Onega T; Advani S; Henderson LM; Wernli KJ; Zhang D; Miglioretti DL; Braithwaite D; Kerlikowske K
Ann Intern Med; 2022 Jan; 175(1):11-19. PubMed ID: 34807717
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
